New peanut allergy drug offers hope

A new drug designed to lessen the potentially life-threatening effects of peanut exposure to those with severe allergies may soon be available. Results of a clinical trial that gradually exposed more than 350 children to peanuts were published on Sunday. By the end of the trial, most of the kids were able to digest the equivalent of two peanuts without having a reaction.